by GlobeNewsWire | Mar 1, 2016 | Globe Newswire
SILVER SPRING, Md., March 01, 2016 (GLOBE NEWSWIRE) — PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology,...
by GlobeNewsWire | Feb 10, 2016 | Globe Newswire, GNW Alerts
SILVER SPRING, Md., Feb. 10, 2016 (GLOBE NEWSWIRE) — PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology,...
by GlobeNewsWire | Jan 25, 2016 | Globe Newswire, GNW Alerts
SILVER SPRING, Md., Jan. 25, 2016 (GLOBE NEWSWIRE) — PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology,...
by GlobeNewsWire | Jan 19, 2016 | Globe Newswire, GNW Alerts
SILVER SPRING, Md., Jan. 19, 2016 (GLOBE NEWSWIRE) — PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology,...
by GlobeNewsWire | Jan 14, 2016 | Globe Newswire, GNW Alerts
SILVER SPRING, Md., Jan. 14, 2016 (GLOBE NEWSWIRE) — PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology,...